Fig. 2From: Prognostic value of CT-based radiomics in grade 1–2 pancreatic neuroendocrine tumorsCalibration plots of the CR model showing the predicted and observed probability of (a) 3-year RFS and (b) 3-year OS in the test set. CR, clinical-radiomics; OS, overall survival; RFS, recurrence-free survivalBack to article page